New Israeli technology provides early detection of cardiac disease, which could save millions of lives around the world.
Biological Signal Processing Ltd. (BSP), based in Tel Aviv, is revolutionizing the diagnosis of heart disease, making early detection more accessible.
Nearly one-third of deaths across the globe are caused by cardiovascular disease, and the problem is a lack of early detection.
Dr. Yair Granot, the company’s CEO, discusses the revolutionary diagnostic tool that helps prevent cardiovascular disease before it strikes.
This new method of analyzing ECG – checking the electrical activity of the heart – is completely safe, Granot says, adding that the results of clinical trials have been extremely positive.
Click below to hear more details of this revolutionary lifesaving technology.